B2VI25 AF NFT

Serine hydroxymethyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeid4kun3btmebkwoh464ecxt3imfs3uywyfw3yvywbwjvtxvnpdegq/metadata.json
IPFS of structure file: 
bafybeiaxgu3anubvs4jvk5uwkfpcgwmoks7a7y2ktkbzi6sd4h2cp2nlyu/AF-B2VI25-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xBeF036C04BE8b62aF43C82A9ec62223aAa892154
First NFT owner address (bech32): 
genesis1hmcrdsztazmz4apus257cc3z824gjg258k4s7r
Current NFT ID #153564 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
153564
Accession (UniProt):
B2VI25
Name::
Serine hydroxymethyltransferase
Experimental Method:
Predicted structure
Sequence source:
Erwinia tasmaniensis (strain DSM 17950 / CFBP 7177 / CIP 109463 / NCPPB 4357 / Et1/99)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2VI25 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2VI25|GLYA_ERWT9 Serine hydroxymethyltransferase OS=Erwinia tasmaniensis (strain DSM 17950 / CFBP 7177 / CIP 109463 / NCPPB 4357 / Et1/99) OX=465817 GN=glyA PE=3 SV=1 MLKRDMNIADYDADLWQAMEQEKVRQEEHIELIASENYTSPRVMQAQGSQLTNKYAEGYPGKRYYGGCEHVDIVEQLAIERAKELFGADYANVQPHSGSQANFAVYTALLQPGDTILGMNLAHGGHLTHGSPVNLSGKLYNVIPYGIDETGKIDYNELAELAKEHQPKMIVGGFSAYSGICDWEKMREIADSIGAYLFVDMAHVAGLVAADVYPNPVPHAHIVTTTTHKTLAGPRGGLILAKGGDEDLYKKLNSGVFPGSQGGPLMHVIAGKAVAFKEAMEPEFKTYQQQVAKNAKAMVEVFLARGYNVVSGGTHNHLFLLDLVDKNLTGKEADAALGRANITVNKNSVPNDPKSPFVTSGIRIGSPAVTRRGFKEAEVRELAGWISDILDNITDEGVSERVKKQVLDICARFPVYA